$CSTL Patients with Uveal Melanoma Tested with DecisionDx®-UM Report Gaining Value from Test Results In Study Conducted In Collaboration with the Melanoma Research Foundation’s CURE OM Initiative

on June 23, 2022 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Castle Adds to Evidence Supporting Its Skin Cancer Test Portfolio through Multiple Data Presentations at the SDPA Annual Summer Dermatology Conference 2022

on June 22, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Castle Biosciences Announces Support for OHSU’s War on Melanoma™

on June 20, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Collaborative Study with Melanoma Research Foundation Confirms Patients Diagnosed with Melanoma Desire Testing with DecisionDx®-Melanoma

on June 14, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Castle Biosciences to Present at the JMP Securities Life Sciences Conference

on June 8, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Castle Biosciences’ DecisionDx®-Melanoma Test Receives 2022 MedTech Breakthrough Award

on May 27, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Data Demonstrating DecisionDx®-Melanoma’s Ability to Risk-Stratify Patients According to Melanoma-Specific Survival to be Shared during the 2022 ASCO Annual Meeting

on May 25, 2022 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL TissueCypher® Outperforms Pathologist Diagnoses When Predicting Progression in Patients Diagnosed with Barrett’s Esophagus with Low-Grade Dysplasia

on May 24, 2022 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Grant From Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer

on May 20, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Data from Second Independent Multi-Center Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Confirms Independent Risk-Stratification Performance of DecisionDx®-SCC

on May 19, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire
Read more

$CSTL Castle Biosciences Presents Data on Its Inflammatory Skin Disease Pipeline Test at the 4th Annual Revolutionizing Atopic Dermatitis (RAD) Conference

on April 18, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Castle Biosciences to Acquire AltheaDx

on April 4, 2022 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Castle Biosciences Receives Advanced Diagnostic Laboratory Test (ADLT) Status for TissueCypher® Barrett’s Esophagus Test from the Centers for Medicare & Medicaid Services (CMS)

on March 29, 2022 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Data to be Presented at the 2022 American Academy of Dermatology (AAD) Annual Meeting Demonstrate Ability of DecisionDx®-Melanoma and DecisionDx®-SCC to Inform Clinical Decision Making

on March 25, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Independent Data Presented at Society for Surgical Oncology Conference Demonstrated DecisionDx®-Melanoma Outperforms T-Stage at Identifying Patients with Low Risk of Sentinel Lymph Node Positivity

on March 11, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Castle Biosciences to Present at Upcoming Investor Conferences

on March 1, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Castle Biosciences Reports Fourth Quarter and Full-Year 2021 Results

on February 28, 2022 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Castle Biosciences to Release Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on Monday, Feb. 28, 2022

on February 14, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Castle Biosciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference

on February 7, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more

$CSTL Recently Published Data Confirm DecisionDx®-SCC as a Significant and Independent Risk-Stratification Tool in Patients with Squamous Cell Carcinoma and One or More Risk Factors

on January 13, 2022 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
CSTL
Source:
Business Wire News Releases
Read more